Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05733442 · ClinicalTrials.gov registry record · NA

Counseling for Harm Reduction and Retention in Medication-assisted Treatment - Cherokee Nation

A NA study of Opioid Use Disorder, sponsored by Washington State University.

Recruiting
Registry status
NA
Development phase
136
Enrollment target
2
Study locations

NCT05733442 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Washington State University. The registered enrollment target is 136 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05733442, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Washington State University.

RECRUITING
Registry status
NA
Development phase
136 participants
Enrollment target
2
Study locations

Study Summary

The goal of this randomized clinical trial is to test the efficacy of a program meant to enhance Counseling for Harm Reduction and Retention in MAT in Cherokee Nation (CHaRRM-CN). The main questions it aims to answer are whether CHaRRM-CN: improves retention of patients in MAT, decreases substance-related harm and illicit opioid use, and increases cultural connectedness. After providing written, informed consent, participants will attend a baseline assessement and will then be randomized to either the CHaRRM-CN or treatment as usual group. For 6 months after randomization, participants will be exposed to CHaRRM-CN or treatment as usual. During that time, participants will also attend the 1-month, 3-month and 6-month follow-ups to track their progress through the programs. After the 6 months of either treatment condition, investigators will compare the groups to see if they differ on retention, substance-use outcomes and Native enculturation.

Conditions Studied

Opioid Use Disorder

Interventions

  • OTHER Treatment as usual (TAU)
  • OTHER CHaRRM-CN

Study Locations (2)

Oklahoma

  • Cherokee Nation Health Services - Tahlequah

Washington

  • University of Washington School of Medicine - Seattle

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2023-01-17
Est. Completion 2025-07-31
Phase NA

Sponsor

Washington State University

64 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05733442

The ClinicalTrials.gov registry entry for NCT05733442 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower). The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual (TAU) is the first listed.

NCT05733442 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Oklahoma, Washington.

Frequently Asked Questions

What is clinical trial NCT05733442 about?

NCT05733442 is a clinical study titled "Counseling for Harm Reduction and Retention in Medication-assisted Treatment - Cherokee Nation". The goal of this randomized clinical trial is to test the efficacy of a program meant to enhance Counseling for Harm Reduction and Retention in MAT in Cherokee Nation (CHaRRM-CN). The main questions it aims to answer are whether CHaRRM-CN: improves retention of patients in MAT, decreases substance-r...

What is the current status of trial NCT05733442?

This trial is currently recruiting. It is a NA study. The enrollment target is 136 participants. The study started on 2023-01-17. Estimated completion is 2025-07-31.

What conditions does trial NCT05733442 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT05733442?

The interventions under investigation include: Treatment as usual (TAU) (OTHER), CHaRRM-CN (OTHER).

Who is sponsoring clinical trial NCT05733442?

This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05733442 being conducted?

This trial has 2 study locations across Oklahoma, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Oklahoma

All trials with a study site in Oklahoma

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.